Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Free Cash Flow (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Free Cash Flow for 7 consecutive years, with -$7.9 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 72.83% to -$7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$49.0 million through Dec 2025, up 9.94% year-over-year, with the annual reading at -$49.0 million for FY2025, 46.92% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$7.9 million at Strata Critical Medical, up from -$37.6 million in the prior quarter.
  • The five-year high for Free Cash Flow was $3.4 million in Q3 2023, with the low at -$37.6 million in Q3 2025.
  • Average Free Cash Flow over 5 years is -$11.1 million, with a median of -$9.1 million recorded in 2022.
  • The sharpest move saw Free Cash Flow tumbled 3753.32% in 2021, then surged 91.22% in 2025.
  • Over 5 years, Free Cash Flow stood at -$6.0 million in 2021, then crashed by 51.51% to -$9.1 million in 2022, then decreased by 2.25% to -$9.3 million in 2023, then plummeted by 212.61% to -$29.1 million in 2024, then surged by 72.83% to -$7.9 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$7.9 million, -$37.6 million, and -$679000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.